Consistent RCTs and MR evidence showed protective roles of ACE inhibitors and CCBs in stroke [13, 23, 55–59], kidney function [6, 60, 61], and diabetes [30, 31, 62], and showed potential harmful effects of BBs on diabetes [30, 31, 60–62]. The gene discussed is ACE; the disease is Stroke.